Production (Stage)
Lixte Biotechnology Holdings, Inc.
LIXT
$1.33
-$0.0502-3.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.38M | 1.04M | 1.64M | 2.60M | 3.41M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 129.50K | 106.60K | 51.30K | 72.40K | 96.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 78.00K |
| Total Current Assets | 1.51M | 1.15M | 1.69M | 2.67M | 3.59M |
|
|
|||||
| Total Current Assets | 1.51M | 1.15M | 1.69M | 2.67M | 3.59M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 6.90K | -- | -- |
| Total Assets | 1.51M | 1.15M | 1.70M | 2.67M | 3.59M |
|
|
|||||
| Total Accounts Payable | 112.50K | 55.70K | 72.90K | 131.40K | 207.90K |
| Total Accrued Expenses | -- | 27.50K | -- | -- | 38.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 242.60K | 235.10K | 256.10K | 290.10K | 216.10K |
| Total Other Current Liabilities | 242.60K | 235.10K | 256.10K | 290.10K | 216.10K |
| Total Current Liabilities | 355.10K | 318.30K | 329.00K | 421.50K | 462.80K |
|
|
|||||
| Total Current Liabilities | 355.10K | 318.30K | 329.00K | 421.50K | 462.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 355.10K | 318.30K | 329.00K | 421.50K | 462.80K |
|
|
|||||
| Common Stock & APIC | 50.44M | 49.39M | 49.32M | 49.21M | 49.08M |
| Retained Earnings | -52.78M | -52.07M | -51.45M | -50.46M | -49.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.34M | -2.67M | -2.13M | -1.25M | -373.60K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M |
|
|
|||||
| Total Common Equity | -2.34M | -2.67M | -2.13M | -1.25M | -373.60K |
| Total Preferred Equity | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.16M | 827.20K | 1.37M | 2.25M | 3.13M |
|
|
|||||